{"date":"2026-06-05","count":32,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-4169-2026-06-05-2142-yqp804","company_id":"4169","company":"泰宗","market":"上市","industry":"生技醫療","date":"2026-06-05","time":"21:42:32","subject":"公告本公司第五屆薪資報酬暨提名委員會委員任期屆滿","clause":"第6款","fact_date":"2026-06-05","cite_as":"公開資訊觀測站重大訊息：泰宗（4169），2026-06-05 21:42，「公告本公司第五屆薪資報酬暨提名委員會委員任期屆滿」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4169-2026-06-05-2142-1ez6nv2","company_id":"4169","company":"泰宗","market":"上市","industry":"生技醫療","date":"2026-06-05","time":"21:42:10","subject":"公告本公司第一屆永續委員會任期屆滿","clause":"第6款","fact_date":"2026-06-05","cite_as":"公開資訊觀測站重大訊息：泰宗（4169），2026-06-05 21:42，「公告本公司第一屆永續委員會任期屆滿」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4169-2026-06-05-2141-2z5pp1","company_id":"4169","company":"泰宗","market":"上市","industry":"生技醫療","date":"2026-06-05","time":"21:41:47","subject":"公告本公司第四屆審計委員會成員及審計委員會召集人","clause":"第6款","fact_date":"2026-06-05","cite_as":"公開資訊觀測站重大訊息：泰宗（4169），2026-06-05 21:41，「公告本公司第四屆審計委員會成員及審計委員會召集人」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4169-2026-06-05-2141-zhkfod","company_id":"4169","company":"泰宗","market":"上市","industry":"生技醫療","date":"2026-06-05","time":"21:41:20","subject":"公告本公司115年股東常會全面改選董事當選名單","clause":"第6款","fact_date":"2026-06-05","cite_as":"公開資訊觀測站重大訊息：泰宗（4169），2026-06-05 21:41，「公告本公司115年股東常會全面改選董事當選名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4169-2026-06-05-2140-uu578p","company_id":"4169","company":"泰宗","market":"上市","industry":"生技醫療","date":"2026-06-05","time":"21:40:57","subject":"本公司115年股東常會決議解除董事競業禁止之限制","clause":"第21款","fact_date":"2026-06-05","cite_as":"公開資訊觀測站重大訊息：泰宗（4169），2026-06-05 21:40，「本公司115年股東常會決議解除董事競業禁止之限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4169-2026-06-05-2140-1jb8ii5","company_id":"4169","company":"泰宗","market":"上市","industry":"生技醫療","date":"2026-06-05","time":"21:40:38","subject":"公告本公司115年股東常會重要決議事項","clause":"第18款","fact_date":"2026-06-05","cite_as":"公開資訊觀測站重大訊息：泰宗（4169），2026-06-05 21:40，「公告本公司115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4169-2026-06-05-2140-17ndua8","company_id":"4169","company":"泰宗","market":"上市","industry":"生技醫療","date":"2026-06-05","time":"21:40:16","subject":"公告本公司董事會選任董事長（續任）","clause":"第6款","fact_date":"2026-06-05","cite_as":"公開資訊觀測站重大訊息：泰宗（4169），2026-06-05 21:40，「公告本公司董事會選任董事長（續任）」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6617-2026-06-05-2105-ty40o6","company_id":"6617","company":"共信-KY","market":"上櫃","industry":"生技醫療","date":"2026-06-05","time":"21:05:23","subject":"代公告重要子公司共信醫藥科技股份有限公司採開放性臨床試驗新藥PTS100用於治療不適合手術或已局部治療失敗的肝癌病患已完成二期臨床試驗收案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：共信-KY（6617），2026-06-05 21:05，「代公告重要子公司共信醫藥科技股份有限公司採開放性臨床試驗新藥PTS100用於治療不適合手術或已局部治療失敗的肝癌病患已完」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1760-2026-06-05-1835-mllx5v","company_id":"1760","company":"寶齡富錦","market":"上市","industry":"生技醫療","date":"2026-06-05","time":"18:35:15","subject":"公告本公司董事會決議通過簽署新藥Nephoxil(枸櫞酸鐵膠囊)之中國大陸授權書","clause":"第51款","fact_date":"2026-06-05","cite_as":"公開資訊觀測站重大訊息：寶齡富錦（1760），2026-06-05 18:35，「公告本公司董事會決議通過簽署新藥Nephoxil(枸櫞酸鐵膠囊)之中國大陸授權書」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4745-2026-06-05-1742-1wvuq7n","company_id":"4745","company":"合富-KY","market":"上櫃","industry":"生技醫療","date":"2026-06-05","time":"17:42:40","subject":"公告本公司董事會決議第四次買回庫藏股事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：合富-KY（4745），2026-06-05 17:42，「公告本公司董事會決議第四次買回庫藏股事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6892-2026-06-05-1700-162kujq","company_id":"6892","company":"台寶生醫","market":"興櫃","industry":"生技醫療","date":"2026-06-05","time":"17:00:59","subject":"公告本公司受邀參加福邦證券舉辦法人說明會","clause":"第30款","fact_date":"2026-06-09","cite_as":"公開資訊觀測站重大訊息：台寶生醫（6892），2026-06-05 17:00，「公告本公司受邀參加福邦證券舉辦法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7725-2026-06-05-1655-d8h6pu","company_id":"7725","company":"列特博","market":"興櫃","industry":"生技醫療","date":"2026-06-05","time":"16:55:52","subject":"公告本公司一年內累積取得同一有價證券達實收資本額百分之二十","clause":"第17款","fact_date":"2026-06-05","cite_as":"公開資訊觀測站重大訊息：列特博（7725），2026-06-05 16:55，「公告本公司一年內累積取得同一有價證券達實收資本額百分之二十」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6676-2026-06-05-1643-1woj8ts","company_id":"6676","company":"祥翊","market":"興櫃","industry":"生技醫療","date":"2026-06-05","time":"16:43:57","subject":"補充私募專區-股款或價款繳納完成日起十五日內應申報相關資訊","clause":"第44款","fact_date":"2026-06-05","cite_as":"公開資訊觀測站重大訊息：祥翊（6676），2026-06-05 16:43，「補充私募專區-股款或價款繳納完成日起十五日內應申報相關資訊」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4164-2026-06-05-1626-uichiq","company_id":"4164","company":"承業醫","market":"上市","industry":"生技醫療","date":"2026-06-05","time":"16:26:55","subject":"公告本公司減少持有被控股公司家數","clause":"第41款","fact_date":"2026-06-05","cite_as":"公開資訊觀測站重大訊息：承業醫（4164），2026-06-05 16:26，「公告本公司減少持有被控股公司家數」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4116-2026-06-05-1619-11rgo76","company_id":"4116","company":"明基醫","market":"上櫃","industry":"生技醫療","date":"2026-06-05","time":"16:19:48","subject":"公告本公司現金股利配息基準日及發放日","clause":"第14款","fact_date":"2026-06-05","cite_as":"公開資訊觀測站重大訊息：明基醫（4116），2026-06-05 16:19，「公告本公司現金股利配息基準日及發放日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3716-2026-06-05-1618-ldd3au","company_id":"3716","company":"中化控股","market":"上市","industry":"生技醫療","date":"2026-06-05","time":"16:18:50","subject":"代子公司「中國化學製藥股份有限公司」公告營運長異動","clause":"第8款","fact_date":"2026-06-05","cite_as":"公開資訊觀測站重大訊息：中化控股（3716），2026-06-05 16:18，「代子公司「中國化學製藥股份有限公司」公告營運長異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6986-2026-06-05-1609-1xeooua","company_id":"6986","company":"和迅","market":"上櫃","industry":"生技醫療","date":"2026-06-05","time":"16:09:50","subject":"公告本公司股票初次上櫃前現金增資認股繳款期間暨暫定承銷價相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：和迅（6986），2026-06-05 16:09，「公告本公司股票初次上櫃前現金增資認股繳款期間暨暫定承銷價相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6986-2026-06-05-1608-1bnswtb","company_id":"6986","company":"和迅","market":"上櫃","industry":"生技醫療","date":"2026-06-05","time":"16:08:12","subject":"公告本公司初次上櫃現金增資委託代收及存儲價款機構","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：和迅（6986），2026-06-05 16:08，「公告本公司初次上櫃現金增資委託代收及存儲價款機構」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4116-2026-06-05-1608-dsn5n6","company_id":"4116","company":"明基醫","market":"上櫃","industry":"生技醫療","date":"2026-06-05","time":"16:08:00","subject":"公告本公司薪資報酬委員會委員任期屆滿改選","clause":"第6款","fact_date":"2026-06-05","cite_as":"公開資訊觀測站重大訊息：明基醫（4116），2026-06-05 16:08，「公告本公司薪資報酬委員會委員任期屆滿改選」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6986-2026-06-05-1606-qkrt5g","company_id":"6986","company":"和迅","market":"上櫃","industry":"生技醫療","date":"2026-06-05","time":"16:06:36","subject":"公告本公司股務代理機構名稱、辦公處所及聯絡電話","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：和迅（6986），2026-06-05 16:06，「公告本公司股務代理機構名稱、辦公處所及聯絡電話」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4116-2026-06-05-1554-r8x24z","company_id":"4116","company":"明基醫","market":"上櫃","industry":"生技醫療","date":"2026-06-05","time":"15:54:33","subject":"公告本公司審計委員會委員任期屆滿改選","clause":"第6款","fact_date":"2026-06-05","cite_as":"公開資訊觀測站重大訊息：明基醫（4116），2026-06-05 15:54，「公告本公司審計委員會委員任期屆滿改選」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6861-2026-06-05-1546-1nxb0oo","company_id":"6861","company":"睿生光電","market":"上市","industry":"生技醫療","date":"2026-06-05","time":"15:46:22","subject":"因本公司有價證券於集中交易市場達公布注意交易資訊標準，故公布相關財務業務等重大訊息，以利投資人區別瞭解","clause":"第51款","fact_date":"2026-06-05","cite_as":"公開資訊觀測站重大訊息：睿生光電（6861），2026-06-05 15:46，「因本公司有價證券於集中交易市場達公布注意交易資訊標準，故公布相關財務業務等重大訊息，以利投資人區別瞭解」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4116-2026-06-05-1536-1gjmh7l","company_id":"4116","company":"明基醫","market":"上櫃","industry":"生技醫療","date":"2026-06-05","time":"15:36:01","subject":"公告本公司董事會推選董事長及副董事長案","clause":"第6款","fact_date":"2026-06-05","cite_as":"公開資訊觀測站重大訊息：明基醫（4116），2026-06-05 15:36，「公告本公司董事會推選董事長及副董事長案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4116-2026-06-05-1515-1a6l1n","company_id":"4116","company":"明基醫","market":"上櫃","industry":"生技醫療","date":"2026-06-05","time":"15:15:28","subject":"公告本公司115年股東常會決議通過解除新任董事及其代表人競業限制案","clause":"第21款","fact_date":"2026-06-05","cite_as":"公開資訊觀測站重大訊息：明基醫（4116），2026-06-05 15:15，「公告本公司115年股東常會決議通過解除新任董事及其代表人競業限制案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7814-2026-06-05-1507-qkrt5g","company_id":"7814","company":"海昌生技","market":"上櫃","industry":"生技醫療","date":"2026-06-05","time":"15:07:21","subject":"公告本公司股務代理機構名稱、辦公處所及聯絡電話","clause":"第44款","fact_date":"2026-06-05","cite_as":"公開資訊觀測站重大訊息：海昌生技（7814），2026-06-05 15:07，「公告本公司股務代理機構名稱、辦公處所及聯絡電話」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7814-2026-06-05-1506-13of8fa","company_id":"7814","company":"海昌生技","market":"上櫃","industry":"生技醫療","date":"2026-06-05","time":"15:06:01","subject":"公告本公司初次上櫃前現金增資委託代收及存儲價款機構","clause":"第44款","fact_date":"2026-06-05","cite_as":"公開資訊觀測站重大訊息：海昌生技（7814），2026-06-05 15:06，「公告本公司初次上櫃前現金增資委託代收及存儲價款機構」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7814-2026-06-05-1504-15chmty","company_id":"7814","company":"海昌生技","market":"上櫃","industry":"生技醫療","date":"2026-06-05","time":"15:04:56","subject":"公告本公司股票初次上櫃前現金增資發行新股相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：海昌生技（7814），2026-06-05 15:04，「公告本公司股票初次上櫃前現金增資發行新股相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4116-2026-06-05-1502-zhkfod","company_id":"4116","company":"明基醫","market":"上櫃","industry":"生技醫療","date":"2026-06-05","time":"15:02:19","subject":"公告本公司115年股東常會全面改選董事當選名單","clause":"第6款","fact_date":"2026-06-05","cite_as":"公開資訊觀測站重大訊息：明基醫（4116），2026-06-05 15:02，「公告本公司115年股東常會全面改選董事當選名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4116-2026-06-05-1449-5x137b","company_id":"4116","company":"明基醫","market":"上櫃","industry":"生技醫療","date":"2026-06-05","time":"14:49:37","subject":"民國115年股東常會重要決議事項公告","clause":"第18款","fact_date":"2026-06-05","cite_as":"公開資訊觀測站重大訊息：明基醫（4116），2026-06-05 14:49，「民國115年股東常會重要決議事項公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4127-2026-06-05-1444-57zjbn","company_id":"4127","company":"天良","market":"上櫃","industry":"生技醫療","date":"2026-06-05","time":"14:44:46","subject":"公告本公司副總經理異動","clause":"第8款","fact_date":"2026-06-05","cite_as":"公開資訊觀測站重大訊息：天良（4127），2026-06-05 14:44，「公告本公司副總經理異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4127-2026-06-05-1444-dpqqwy","company_id":"4127","company":"天良","market":"上櫃","industry":"生技醫療","date":"2026-06-05","time":"14:44:07","subject":"公告本公司發言人、財務主管暨會計主管、公司治理主管異動","clause":"第8款","fact_date":"2026-06-05","cite_as":"公開資訊觀測站重大訊息：天良（4127），2026-06-05 14:44，「公告本公司發言人、財務主管暨會計主管、公司治理主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7759-2026-06-05-1015-1fqkmsr","company_id":"7759","company":"視航生醫","market":"興櫃","industry":"生技醫療","date":"2026-06-05","time":"10:15:23","subject":"澄清媒體報導","clause":"第26款","fact_date":"2026-06-05","cite_as":"公開資訊觀測站重大訊息：視航生醫（7759），2026-06-05 10:15，「澄清媒體報導」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}